Evrysdi is
Proven to make a difference in infants, children, and adults
with spinal muscular atrophy (SMA)
In people 2 months and older

How Evrysdi is being studied
More than 450 people with SMA, from 2 months to 60 years of age, are
participating in the clinical studies

Taking Evrysdi
Evrysdi is the first and only at-home oral treatment for SMA

Get personal support
MySMA Support can help you learn more about Evrysdi and insurance
coverage options